45
Participants
Start Date
August 1, 2025
Primary Completion Date
May 1, 2028
Study Completion Date
May 1, 2028
Fludarabine; melphalan; busulfan
The conditioning regimen includes fludarabine, busulfan, and melphalan, with a transplant conditioning intensity of 3.0. The RIC is used in the allo-HCT in the MDS patients.
Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai
Wuhan TongJi Hospital
OTHER
Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology
UNKNOWN
Zhejiang University
OTHER
Ruijin Hospital
OTHER